| Metric | FY 2013 | Prior Q | FY 2012 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $92M | — | — | — | — |
| Op. Income | $21M | — | — | — | — |
| Gross Margin | 90.0% | — | — | — | — |
| Net Margin | 15.7% | — | — | — | — |
| EPS (Diluted) | $0.66 | — | — | — | — |
| Free Cash Flow | $27M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $92M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $83M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $32M |
| SG&A Expenses | $33M |
| Other Expenses | $29M |
| Operating Expenses | $63M |
| Cost & Expenses | $72M |
| OPERATING INCOME | $21M |
| Interest Income | $75M |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $5M |
| EBIT | $21M |
| EBITDA | $26M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $92M |
| Cost of Revenue | $9M |
| GROSS PROFIT | $83M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $32M |
| SG&A Expenses | $33M |
| Other Expenses | $29M |
| Operating Expenses | $63M |
| Cost & Expenses | $72M |
| OPERATING INCOME | $21M |
| Interest Income | $75M |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $21M |
| Income Tax Expense | $6M |
| Net Income from Continuing Ops | $15M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $15M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $10M |
| D&A | $5M |
| EBIT | $21M |
| EBITDA | $26M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $15M |
| Depreciation & Amortization | $5M |
| Stock-Based Compensation | $358.0K |
| Deferred Income Tax | $1M |
| Other Non-Cash Items | $8M |
| Change in Working Capital | $2M |
| OPERATING CASH FLOW | $31M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | $14M |
| Purchases of Investments | -$96M |
| Sales/Maturities of Investments | $165M |
| Other Investing Activities | -$180M |
| NET CASH FROM INVESTING | -$100M |
| Net Debt Issuance | $14M |
| Common Stock Repurchased | -$9.0K |
| Common Dividends Paid | -$2M |
| Other Financing Activities | $33M |
| NET CASH FROM FINANCING | $42M |
| FREE CASH FLOW | $27M |
| Net Change in Cash | -$27M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $87M |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $87M |
| PP&E (Net) | $54M |
| Goodwill | $8M |
| Intangible Assets | $8M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $1.6B |
| TOTAL NON-CURRENT ASSETS | $1.7B |
| TOTAL ASSETS | $1.7B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $636.0K |
| Long-Term Debt | $93M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $1.5B |
| TOTAL NON-CURRENT LIABILITIES | $1.6B |
| TOTAL LIABILITIES | $1.6B |
| Common Stock | $50.0K |
| Additional Paid-In Capital | $15M |
| Retained Earnings | $75M |
| Treasury Stock | -$4M |
| Accum. Other Comp. Income | $7M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $149M |
| Minority Interest | $0 |
| TOTAL EQUITY | $149M |
| TOTAL LIABILITIES & EQUITY | $1.7B |
| Total Debt | $93M |
| Net Debt | $6M |
